- Home
- Publications
- Publication Search
- Publication Details
Title
The role of GATA2 in lethal prostate cancer aggressiveness
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 14, Issue 1, Pages 38-48
Publisher
Springer Nature
Online
2016-11-22
DOI
10.1038/nrurol.2016.225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drugging Undruggable Molecular Cancer Targets
- (2016) John S. Lazo et al. Annual Review of Pharmacology and Toxicology
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
- (2016) J C Zhao et al. ONCOGENE
- The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study
- (2016) Hakim Mahammedi et al. ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
- (2015) Samuel J. Vidal et al. CANCER CELL
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis
- (2015) Alexey A. Dmitriev et al. DISEASE MARKERS
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
- (2015) Laurence Klotz et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- The oncogene ERG: a key factor in prostate cancer
- (2015) P Adamo et al. ONCOGENE
- A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination
- (2015) Channing J. Paller et al. PROSTATE
- Curcumin Targets in Inflammation and Cancer
- (2015) Atsuko Deguchi Endocrine Metabolic & Immune Disorders-Drug Targets
- GATA2 as a potential metastasis-driving gene in prostate cancer
- (2015) Yan Ting Chiang et al. Oncotarget
- Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
- (2014) Subash C. Gupta et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- p38 links RAS to GATA2
- (2014) C. Baumgartner et al. EMBO REPORTS
- Molecular basis of crosstalk between oncogenic Ras and the master regulator of hematopoiesis GATA-2
- (2014) K. R. Katsumura et al. EMBO REPORTS
- Pioneer transcription factors in cell reprogramming
- (2014) Makiko Iwafuchi-Doi et al. GENES & DEVELOPMENT
- A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation
- (2014) Takashi Moriguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia
- (2014) M Celton et al. LEUKEMIA
- NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
- (2014) Angela N. Flores et al. Nature Reviews Urology
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
- (2014) Bin He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study
- (2014) R Thomas et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Notch Delta-4 ligand helps to maintain the quiescence and the short-term reconstitutive potential of haematopoietic progenitor cells through activation of a key gene network
- (2014) Cyril Catelain et al. Stem Cell Research
- Lysine-Specific Demethylase 1 Has Dual Functions as a Major Regulator of Androgen Receptor Transcriptional Activity
- (2014) Changmeng Cai et al. Cell Reports
- GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2
- (2013) Silvia Coma et al. ANGIOGENESIS
- RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity
- (2013) S. Cellot et al. BLOOD
- GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
- (2013) M. A. Spinner et al. BLOOD
- IGF2 and cancer
- (2013) Callum Livingstone ENDOCRINE-RELATED CANCER
- Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication
- (2013) Annelies Gonnissen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SON Protein Regulates GATA-2 through Transcriptional Control of the MicroRNA 23a∼27a∼24-2 Cluster
- (2013) Erin Eun-Young Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Castration-Resistant Prostate Cancer: AUA Guideline
- (2013) Michael S. Cookson et al. JOURNAL OF UROLOGY
- Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia
- (2013) E H Estey LEUKEMIA
- Hypoxia, notch signalling and prostate cancer
- (2013) Laure Marignol et al. Nature Reviews Urology
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Homopiperazine Derivatives as a Novel Class of Proteasome Inhibitors with a Unique Mode of Proteasome Binding
- (2013) Jiro Kikuchi et al. PLoS One
- Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
- (2012) Josep Domingo-Domenech et al. CANCER CELL
- Targeting Pioneering Factor and Hormone Receptor Cooperative Pathways to Suppress Tumor Progression
- (2012) S. Shah et al. CANCER RESEARCH
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling
- (2012) Jordi Guiu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Adaptation or selection—mechanisms of castration-resistant prostate cancer
- (2012) Yang Zong et al. Nature Reviews Urology
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
- (2012) E. H. Bresnick et al. NUCLEIC ACIDS RESEARCH
- Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
- (2011) R. E. Dickinson et al. BLOOD
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
- (2011) A. P. Hsu et al. BLOOD
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- The role of the GATA2 transcription factor in normal and malignant hematopoiesis
- (2011) Carmen Vicente et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth
- (2011) Zhong Chen et al. EMBO JOURNAL
- Pioneer transcription factors: establishing competence for gene expression
- (2011) K. S. Zaret et al. GENES & DEVELOPMENT
- ERG dependence distinguishes developmental control of hematopoietic stem cell maintenance from hematopoietic specification
- (2011) S. Taoudi et al. GENES & DEVELOPMENT
- Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
- (2011) Pia Ostergaard et al. NATURE GENETICS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs Associated with Metastatic Prostate Cancer
- (2011) Akira Watahiki et al. PLoS One
- Quantitative Models of the Mechanisms That Control Genome-Wide Patterns of Transcription Factor Binding during Early Drosophila Development
- (2011) Tommy Kaplan et al. PLoS Genetics
- Emberger syndrome-Primary lymphedema with myelodysplasia: Report of seven new cases
- (2010) Sahar Mansour et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- The Notch2–Jagged1 interaction mediates stem cell factor signaling in erythropoiesis
- (2010) A Zeuner et al. CELL DEATH AND DIFFERENTIATION
- Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation
- (2010) Qihuang Jin et al. EMBO JOURNAL
- GATA Switches as Developmental Drivers
- (2010) Emery H. Bresnick et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen
- (2010) Hisamitsu Ide et al. PROSTATE
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer
- (2010) Karen E. Knudsen et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor
- (2009) Mark J Mulvihill et al. Future Medicinal Chemistry
- Molecular mechanisms of castration-resistant prostate cancer progression
- (2009) Smitha S Dutt et al. Future Oncology
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes
- (2009) M Böhm et al. ONCOGENE
- A Boost of BMP4 Accelerates the Commitment of Human Embryonic Stem Cells to the Endothelial Lineage
- (2009) Orit Goldman et al. STEM CELLS
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
- (2009) William P Harris et al. Nature clinical practice. Urology
- Molecular and developmental biology of the hemangioblast
- (2008) Jing-Wei Xiong DEVELOPMENTAL DYNAMICS
- Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1
- (2008) Àlex Robert-Moreno et al. EMBO JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now